Insight Into Intestinal Microbiome In Nsclc Patients: More Personalized Immunotherapy In The Crosshairs

A. Grenda, E. Iwan,P. Krawczyk, M. Slomiany-Szwarc,A. Bomba,I. Chmielewska,M. Szczyrek,A. Rolska-Kopinska,R. Kieszko, M. Frak,D. Wasyl,J. Milanowski

Journal of Thoracic Oncology（2021）

引用 0|浏览0

暂无评分

摘要

Intestinal bacteria are associated with the functioning of the immune system. The composition of the intestinal microbiome may be associated with the effectiveness of anti-PD-1 or anti-PD-L1 immunotherapy in patients with cancers including non-small cell lung cancer (NSCLC).

查看译文

关键词

Next Generation Sequencing, immunotherapy of NSCLC patients, microbiome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要